Literature DB >> 14564081

Induction of atherosclerosis by human chylomicron remnants: a hypothesis.

Monica G Wilhelm1, Allen D Cooper.   

Abstract

Epidemiologic studies have provided support for the association between delayed remnant removal and premature atherosclerosis. Triglyceride-rich particles such as chylomicrons and chylomicron remnants that carry dietary derived fats, may play a role in the early stages of developing arteriosclerosis. Currently research focuses on these lipoprotein classes seeking distinguishing factors that causes some lipoproteins to be atherogenic while others are not. Such lipoproteins could be involved in atherogenesis directly or indirectly. Direct involvement occurs by interaction of triglyceride-rich particles with the arterial wall, possibly affecting the artery wall by oxidative stress, direct endothelial toxicity by constituents such as lysophosphatidylcholine or oxysterols, induction of prothrombotic changes, stimulation of endothelial expression of cell adhesion molecules and direct interaction with circulating blood cells. Indirect involvement refers to the influence of triglyceride-rich lipoproteins on other lipoproteins on the composition of low density lipoprotein (LDL) and high density lipoprotein (HDL) particles. We propose that in individuals with delayed removal of chylomicron remnants, the prolonged exposure of areas of endothelium that have been partially activated by turbulent flow, to specific components of the remnants, results in the endothelial cells becoming further activated and able to bind monocytes. During or shortly after the transcytosis to the intima and transformation of monocytes to macrophages, the macrophages become engorged with remnant derived lipids and form the nidus of a fatty streak.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564081     DOI: 10.5551/jat.10.132

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  16 in total

1.  After chylomicron remnants, what is left?

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2004-06-10       Impact factor: 4.599

2.  Hemolyzed plasma samples in diabetic ketoacidosis (DKA).

Authors:  L Sojo; A M Wägner; J Ordóñez; R Corcoy
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

3.  The impact of fasting on the interpretation of triglyceride levels for predicting myocardial infarction risk in HIV-positive individuals: the D:A:D study.

Authors: 
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

Review 4.  Remnant lipoproteins and atherosclerosis.

Authors:  ThB Twickler; G M Dallinga-Thie; M J Chapman; J S Cohn
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

5.  A sodium-bicarbonated mineral water reduces gallbladder emptying and postprandial lipaemia: a randomised four-way crossover study.

Authors:  Laura Toxqui; Ana M Pérez-Granados; Ruth Blanco-Rojo; M Pilar Vaquero
Journal:  Eur J Nutr       Date:  2011-09-13       Impact factor: 5.614

6.  Triacylglycerol-rich lipoproteins derived from healthy donors fed different olive oils modulate cytokine secretion and cyclooxygenase-2 expression in macrophages: the potential role of oleanolic acid.

Authors:  V S Graham; C Lawson; C P D Wheeler-Jones; J S Perona; V Ruiz-Gutierrez; K M Botham
Journal:  Eur J Nutr       Date:  2011-06-17       Impact factor: 5.614

7.  Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.

Authors:  P Perron; D Brisson; M Santuré; P Blackburn; J Bergeron; M C Vohl; J P Després; D Gaudet
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

8.  The oxidative state of chylomicron remnants influences their modulation of human monocyte activation.

Authors:  Sandra Armengol Lopez; Kathleen M Botham; Charlotte Lawson
Journal:  Int J Vasc Med       Date:  2011-09-27

Review 9.  Icosapent ethyl for the treatment of severe hypertriglyceridemia.

Authors:  Hassan Fares; Carl J Lavie; James J DiNicolantonio; James H O'Keefe; Richard V Milani
Journal:  Ther Clin Risk Manag       Date:  2014-06-24       Impact factor: 2.423

10.  Fasting versus post-challenge triglycerides and pre-existing cavitating lacunes: a berlin "cream & sugar" substudy.

Authors:  Christopher O Leonards; Li Wang; Jochen B Fiebach; Matthias Endres; Martin Ebinger
Journal:  Front Neurol       Date:  2013-07-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.